NCT01475058
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +27 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
1,435 public trials
165 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT00416624
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
AMG 319 Lymphoid Malignancy FIH
NCT01300026
- Conditions
- Cancer, Chronic Disease, Chronic Lymphocytic Leukemia, +33 more
- Locations
-
- Research Site Hackensack, New Jersey, United States
- Research Site Durham, North Carolina, United States
- Research Site Salt Lake City, Utah, United States
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
NCT00201682
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00143065
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Ohio State University Columbus, Ohio, United States
NCT00233506
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01300247
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Huntsville, Alabama, United States
- Duarte, California, United States
- La Jolla, California, United States
- Los Angeles, California, United States
NCT02042911
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Fukuyama, Hiroshima, Japan
- Research Site Kagoshima, Kagoshima-ken, Japan
- Research Site Isehara, Kanagawa, Japan
Completed
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
NCT01520922
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- Novartis Investigative Site Tuscon, Arizona, United States
- Novartis Investigative Site Aurora, Colorado, United States
- Novartis Investigative Site Fort Myers, Florida, United States
- Novartis Investigative Site St. Petersburg, Florida, United States